Penny stocks with strong FII holding get DSIR recognition for in-house R&D units

with market value 644.49 Crore, Vikas Lifecare Limited is a Small-cap business operating in the Commercial Services industry. Vikas Lifecare Limited is a leading international supplier of premium specialty chemicals. The main business of the company is manufacturing and trading of PVC and plastic products. The company today announced that the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India (DSIR) has recognized its in-house R&D unit.

Vikas Lifecare said that this prestigious DSIR recognition instituted by the Government of India for benchmarking industrial R&D not only acknowledges the supremacy, excellence research work and innovations of the company’s in-house R&D activities but also motivates us to sustain our R&D activities. Also encourages. at par with international standards.

This DSIR recognition for the company’s in-house R&D units makes it possible to obtain funds for R&D purposes from various government departments and agencies, and it enables the company to further invest in essential equipment with low or nil tax liability as R&D units enables to do. Imports can now be made with 100% customs duty exemption, while home appliance purchases will attract a lower GST rate of only 5%. Additionally, a product developed by an R&D unit that has two patents – one from India and the other from another country (US, China, or the European Union) – is eligible for a period of three years during which it can be used without paying excise duty. Marketing can be done. do.

The recognition and further benefits will help VLL to generate additional revenue through manufacture of exclusive content and/or sale of in-house technology to produce such content and/or royalty fee generated from the technology/technology to other producers of similar content is given to, said Vikas Lifecare in an announcement.

Ravi Singh, Vice President and Head of Research, SHARE India, said, “Vikas Lifecare has consistently expanded its business into newer segments. Due to this, good growth can be expected in its business in the coming years. The company also posted better financial numbers on a YoY basis with improved EBITDA margin. There may be some upside in the stock in the near future.

Vikas Lifecare shares closed today on BSE 4.48 each level, down 0.67% from previous close 4.51. The stock recorded a total volume of 14,539,732 shares as compared to 20-day average volume of 13,142,203 shares. The stock touched a 52-week high At 8.15 (21/01/2022) and at 52-week low 3.63 on (12/05/2022). For the quarter ending September 2022 or Q2FY23, the company posted promoter shareholding of 12.27%, FII holding of 9.58% and public shareholding of 78.15%.


Know your inner investor
Do you have guts of steel or are you a victim of insomnia regarding your investments? Let’s define your investment approach.

test

catch ’em all business News, market news, breaking news events and breaking news Update on Live Mint. download mint news app To get daily market updates.

More
Less